Celadon Pharmaceuticals Past Performance
How has Celadon Pharmaceuticals performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: CEL is currently unprofitable.
Growing Profit Margin: CEL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CEL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare CEL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CEL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (5.6%).
Return on Equity
High ROE: CEL has a negative Return on Equity (-110.02%), as it is currently unprofitable.